EverGlade Consulting Assists Appili Therapeutics in Successful Pursuit of DTRA Funding

Biodefense with digital shield and viral strains

EverGlade Consulting (“EverGlade”), a national consulting firm, has helped Appili Therapeutics USA Inc. (“Appili”), a biopharmaceutical company focused on drug development for infectious diseases and biodefense, secure an initial contract with the U.S. Air Force Academy (USAFA). USAFA is the prime contractor to DTRA for this program. 

Scroll to Top